Is pharmacologic prophylaxis indicated for prevention of thromboembolic disease after robotic and laparoscopic hysterectomy in a gynecologic oncology practice? Analysis of morbidity and cost in 1,335 cases

Salom, Emery

373 - Poster Session B
Is pharmacologic prophylaxis indicated for prevention of thromboembolic disease after robotic and laparoscopic hysterectomy in a gynecologic oncology practice? Analysis of morbidity and cost in 1,335 cases

Sunday, March 23, 2014: 5:20 PM

West Exhibit Hall (Tampa Convention Center)

E. M. Salom¹ and M. A. Penalver²
¹Florida International University, Miami Springs, FL, ²Florida International University, Herbert Wertheim College of Medicine, Coral Gables, FL

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

373 - Poster Session B
Is pharmacologic prophylaxis indicated for prevention of thromboembolic disease after robotic and laparoscopic hysterectomy in a gynecologic oncology practice? Analysis of morbidity and cost in 1,335 cases

373 - Poster Session B Is pharmacologic prophylaxis indicated for prevention of thromboembolic disease after robotic and laparoscopic hysterectomy in a gynecologic oncology practice? Analysis of morbidity and cost in 1,335 cases

373 - Poster Session B
Is pharmacologic prophylaxis indicated for prevention of thromboembolic disease after robotic and laparoscopic hysterectomy in a gynecologic oncology practice? Analysis of morbidity and cost in 1,335 cases